The Big Reshuffle — Impact Assessments and System Criticality

A big reshuffle has been made in one of the principal guidelines for Commissioning & Qualification (C&Q) within the pharmaceutical industry today. The changes seek to improve the application of Quality Risk Management (QRM), a growing element of regulatory expectation. This research investigates the impact and implications of the changes to a key area of […]

To access this post, you must purchase MEMBER PLUS +.

You must log in to view this content.

A big reshuffle has been made in one of the principal guidelines for Commissioning & Qualification (C&Q) within the pharmaceutical industry today. The changes seek to improve the application of Quality Risk Management (QRM), a growing element of regulatory expectation. This research investigates the impact and implications of the changes to a key area of […]
To access this post, you must purchase MEMBER PLUS +.

Become a Member to View this Content

Please provide your information below